Does night-time cortisol excretion normalize in the long-term course of depression?

Pharmacopsychiatry

Volumn 43, Issue 5, 2010, Pages 161-165

  Scharnholz, B ^a   Lederbogen, F ^a   Feuerhack, A ^a   Bach, A ^a   Kopf, D ^a,b   Frankhauser, P ^a   Onken, V ^a   Schilling, C ^a   Gilles, M ^a   Hamann, B ^a,c   Deuschle, M ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b Bethanien Krankenhauses Geriatrisches Zentrum   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; MIRTAZAPINE; VENLAFAXINE; ANTIDEPRESSANT AGENT; CYCLOHEXANOL DERIVATIVE; MIANSERIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE RELEASE; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; STANDARDIZATION; ANALOGS AND DERIVATIVES; DEPRESSIVE DISORDER; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; TIME; URINE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CIRCADIAN RHYTHM; CYCLOHEXANOLS; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIANSERIN; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; TIME FACTORS;

EID: 77954871164     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0030-1248316     Document Type: Article

References (25)

1. Ahrens T, Deuschle M, Krumm B, et al. Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from major depression. Psychosomatic Med 2008 70 461-467
2. Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: does cortisol play a role? Biol Psychiatry 2004 55 1-9
3. Bschorr T, Baethge C, Adli M, et al. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression. Depression and Anxiety 2003 17 43-48
4. Colla M, Kronenberg G, Deuschle M, et al. Hippocampal volume reduction and HPA system activity in major depression. J Psychiatr Res 2007 41 553-560
5. Deshauer D, Grof E, Alda M, et al. Patterns of DST positivity in remitted affective disorders. Biol Psychiatry 1999 45 1023-1029
6. Enns MW, Larsen DK, Cox B. Discrepancies between self and observer ratings of depression. The relationship to demographic, clinical and personality variables. J Affective Disord 2000 60 33-41
7. Hatzinger M, Hemmeter UM, Baumann K, et al. The combined DEX-CRH test in treatment course and long-term outcome of major depression. J Psychiatric Res 2002 36 287-297
8. Judd LL, Akiskal HS, Maser JD, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998 54 989-991
9. Kathol RG. Persistent elevation of urinary free cortisol and loss of circannual periodicity in recovered depressive patients: a trait finding. J Affective Disord 1985 8 137-145
10. Kloiber S, Ising M, Reppermund S, et al. Overweight and obesity affect treatment response in major depression. Biol Psychiatry 2007 62 321-326
11. Laakmann G, Hennig J, Baghai T, et al. Influence of mirtazapine on salivary cortisol in depressed patients. Neuropsychobiology 2003 47 31-36 (Pubitemid 36469784)
12. Linkowski P, Mendlewicz J, Leclercq R, et al. The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab 1985 61 429-438 (Pubitemid 15243950)
13. Maes M, Lin A, Bonaccorso S, et al. Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatrica Scandinavica 1998 98 328-335
14. McEwen B. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 2000 22 108-124
15. Scharnholz B, Weber-Hamann B, Lederbogen F, et al. Antidepressive treatment with mirtazapine, but not venlafaxine lowers cortisol concentrations in saliva: a randomised open trial. Psychiatry Res in press
16. Schüle C, Baghai T, Bidlingmaier M, et al. Endocrinological effects of mirtazapine in healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry 2002 26 1253-1261
17. Schüle C, Baghai T, Rackwitz C, et al. Influence of mirtazapine on urinary free cortisol excretion in depressed patients. Psychiatry Res 2003 120 257-264 (Pubitemid 38366053)
18. Schweiger U, Deuschle M, Körner A, et al. Low lumbar bone mineral density in patients with major depression. Am J Psychiatry 1994 151 1691-1693
19. Steiger A, Holsboer F. Nocturnal secretion of prolactin and cortisol and the sleep EEG in patients with major endogenous depression during an acute episode and after full remission. Psychiatry Res 1997 72 81-88
20. Vythilingam M, Vermetten E, Anderson GM, et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry 2004 56 101-112
21. Weber-Hamann B, Kopf D, Lederbogen F, et al. Activity of the hypothalamus-pituitary-adrenal system and oral glucose tolerance in depressed patients. Neuroendocrinology 2005 81 200-204
22. Weber-Hamann B, Werner M, Hentschel F, et al. Metabolic changes in elderly patients with major depression: evidence for increased accumulation of visceral fat at follow-up. Psychoneuroendocrinology 2006 31 347-354
23. Yang TT, Hsiao FH, Wang KC, et al. The effect of psychotherapy added to pharmacotherapy on cortisol responses in outpatients with major depressive disorder. J Nerv Ment Dis 2009 197 401-406
24. Yehuda R, Halligan SL, Yang RK, et al. Relationship between 24-hour urinary-free cortisol excretion and salivary cortisol levels sampled from awakening to bedtime in healthy subjects. Life Sciences 2003 73 349-358
25. Zobel AW, Nickel T, Sonntag A, et al. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression A prospective study. J Psychiatric Res 2001 35 83-94